Comparison of Stent Strut Coverage Between Third Generation Drug-Eluting Stent SYNERGY And Second Generation Drug-Eluting Stent XIENCE Following Stent Implantation In ST-Segment Elevation Myocardial Infarction (STEMI) Patients

Trial Profile

Comparison of Stent Strut Coverage Between Third Generation Drug-Eluting Stent SYNERGY And Second Generation Drug-Eluting Stent XIENCE Following Stent Implantation In ST-Segment Elevation Myocardial Infarction (STEMI) Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Dec 2016

At a glance

  • Drugs Everolimus (Primary)
  • Indications Coronary artery restenosis; Myocardial infarction
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Dec 2016 New trial record
    • 16 Nov 2016 Results presented at the 89th Annual Scientific Sessions of the American Heart Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top